HCG + Beta Fast Test Kit - India CDSCO Medical Device Registration

HCG + Beta Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000153_7fbbf31075b40c0a44df84c3d29227a6_5b460de4ceb5fa375af252789924538d. This device is marketed under the brand name Immunofluorescence Assay. The license holder is Cipla Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

HCG + Beta Fast Test Kit

UID: IMP/IVD/2022/000153_7fbbf31075b40c0a44df84c3d29227a6_5b460de4ceb5fa375af252789924538d

Brand Name

Immunofluorescence Assay

License Holder

Cipla Limited

Device Class

Class C

Approving Authority

CDSCO

Product Information

HCG +β fast test kit is intended for in vitro quantitative determination of human chorionic gonadotropin (Immunofluorescence Assay) in serum or plasma. This test is used as an aid in pregnancy test